betaARKct gene therapy (Genzyme)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamebetaARKct gene therapy (Genzyme)
Drug Alias NamebetaARKct (Genzyme/Duke University)gene therapy (Genzyme/Duke University)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionAdrenergic modulators
TargetsUpdating
Therapy Area/IndicationsCoronary RestenosisHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenzyme Corp
Active IndicationsN/A
Inactive IndicationsCoronary RestenosisHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A